AAAAAA
Results: 1-25/26
Authors:
Noerager, BD
Inuzuka, T
Kira, J
Blalock, JE
Whitaker, JN
Galin, FS
Citation: Bd. Noerager et al., An IgM anti-MBP Ab in a case of Waldenstrom's macroglobulinemia with polyneuropathy expressing an idiotype reactive with an MBP epitope immunodominant in MS and EAE, J NEUROIMM, 113(1), 2001, pp. 163-169
Authors:
Sun, DM
Whitaker, JN
Huang, ZG
Liu, D
Coleclough, C
Wekerle, H
Raine, CS
Citation: Dm. Sun et al., Myelin antigen-specific CD8(+) T cells are encephalitogenic and produce severe disease in C57BL/6 mice, J IMMUNOL, 166(12), 2001, pp. 7579-7587
Authors:
Whitaker, JN
Citation: Jn. Whitaker, Triptans for migraine headache: Therapeutic progress meets a heterogeneouspatient response, ARCH NEUROL, 58(9), 2001, pp. 1482-1483
Authors:
Whitaker, JN
Citation: Jn. Whitaker, Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis, ARCH NEUROL, 58(8), 2001, pp. 1301-1301
Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial
Authors:
Cohen, JA
Cutter, GR
Fischer, JS
Goodman, AD
Heidenreich, FR
Jak, AJ
Kniker, JE
Kooijmans, MF
Lull, JM
Sandrock, AW
Simon, JH
Simonian, NA
Whitaker, JN
Citation: Ja. Cohen et al., Use of the Multiple Sclerosis Functional Composite as an outcome measure in a phase 3 clinical trial, ARCH NEUROL, 58(6), 2001, pp. 961-967
Authors:
Whitaker, JN
Citation: Jn. Whitaker, The potential for harm or benefit from inflammatory processes in stroke, ARCH NEUROL, 58(4), 2001, pp. 674-674
Authors:
Whitaker, JN
Citation: Jn. Whitaker, Medical and endovascular therapy for intracranial atherosclerotic vasculardisease, ARCH NEUROL, 58(10), 2001, pp. 1692-1693
Authors:
Whitaker, JN
Wolinsky, JS
Narayana, PA
Bartolucci, AA
Noseworthy, JH
Lublin, FD
Linde, A
Gjorstrup, P
Sullivan, HC
Citation: Jn. Whitaker et al., Relationship of urinary myelin basic protein-like material with cranial magnetic resonance imaging in advanced multiple sclerosis, ARCH NEUROL, 58(1), 2001, pp. 49-54
Authors:
Whitaker, JN
Citation: Jn. Whitaker, Management of Moyamoya syndrome, ARCH NEUROL, 58(1), 2001, pp. 132-132
Authors:
Bashir, K
Whitaker, JN
Citation: K. Bashir et Jn. Whitaker, Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI, MULT SCLER, 6(5), 2000, pp. 312-316
Authors:
Tranquill, LR
Cao, LG
Ling, NC
Kalbacher, H
Martin, RM
Whitaker, JN
Citation: Lr. Tranquill et al., Enhanced T cell responsiveness to citrulline-containing myelin basic protein in multiple sclerosis patients, MULT SCLER, 6(4), 2000, pp. 220-225
Authors:
LaGanke, CC
Freeman, DW
Whitaker, JN
Citation: Cc. Laganke et al., Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiplesclerosis, ANN NEUROL, 47(1), 2000, pp. 87-92
Authors:
Cao, LG
Sun, DM
Cruz, T
Moscarello, MA
Ludwin, SK
Whitaker, JN
Citation: Lg. Cao et al., Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel, J NEUROIMM, 108(1-2), 2000, pp. 103-111
Authors:
Bashir, K
Cai, CY
Moore, TA
Whitaker, JN
Hadley, MN
Citation: K. Bashir et al., Surgery for cervical spinal cord compression in patients with multiple sclerosis, NEUROSURGER, 47(3), 2000, pp. 637-642
Authors:
Noseworthy, JH
Wolinsky, JS
Lublin, FD
Whitaker, JN
Linde, A
Gjorstrup, P
Sullivan, HC
Citation: Jh. Noseworthy et al., Linomide in relapsing and secondary progressive MS - Part I: Trial design and clinical results, NEUROLOGY, 54(9), 2000, pp. 1726-1733
Authors:
Wolinsky, JS
Narayana, PA
Noseworthy, JH
Lublin, FD
Whitaker, JN
Linde, A
Gjorstrup, P
Sullivan, HC
Citation: Js. Wolinsky et al., Linomide in relapsing and secondary progressive MS - Part II: MRI results, NEUROLOGY, 54(9), 2000, pp. 1734-1741
Authors:
Kaufman, DI
Trobe, JD
Eggenberger, ER
Whitaker, JN
Citation: Di. Kaufman et al., Practice parameter: The role of corticosteroids in the management of acutemonosymptomatic optic neuritis - Report of the Quality Standards Subcommittee of the American Academy of Neurology, NEUROLOGY, 54(11), 2000, pp. 2039-2044
Authors:
Whitaker, JN
Citation: Jn. Whitaker, Neurobiological understanding of myelination in the 21st century, ARCH NEUROL, 57(1), 2000, pp. 57-58
Authors:
Cao, LG
Kirk, MC
Coward, LU
Jackson, P
Whitaker, JN
Citation: Lg. Cao et al., p-Cresol sulfate is the dominant component of urinary myelin basic proteinlike material, ARCH BIOCH, 377(1), 2000, pp. 9-21
Authors:
Sun, DM
Whitaker, JN
Wilson, DB
Citation: Dm. Sun et al., Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease, INT IMMUNOL, 11(3), 1999, pp. 307-315
Authors:
Sun, DM
Coleclough, C
Ji, R
Hu, XZ
Whitaker, JN
Citation: Dm. Sun et al., Alanine-substituted peptide ligands differ greatly in their ability to activate autoreactive T-cell subsets specific for the wild-type peptide, J NEUROIMM, 99(1), 1999, pp. 105-113
Authors:
Blalock, JE
Zhou, SR
Maier, CC
Galin, FS
Whitaker, JN
Citation: Je. Blalock et al., Highly related immunoglobulin light chain sequences in different multiple sclerosis patients, J NEUROIMM, 100(1-2), 1999, pp. 98-101
Authors:
Bashir, E
Whitaker, JN
Citation: E. Bashir et Jn. Whitaker, Clinical and laboratory features of primary progressive and secondary progressive MS, NEUROLOGY, 53(4), 1999, pp. 765-771
Authors:
Sun, DM
Whitaker, JN
Wilson, DB
Citation: Dm. Sun et al., Regulatory T cells in experimental allergic encephalomyelitis. III. Comparison of disease resistance in Lewis and Fischer 344 rats, EUR J IMMUN, 29(4), 1999, pp. 1101-1106
Authors:
Cao, LG
Goodin, R
Wood, D
Moscarello, MA
Whitaker, JN
Citation: Lg. Cao et al., Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein, BIOCHEM, 38(19), 1999, pp. 6157-6163